he medical establishment and mainstream media are uniting against the Trump administration’s re-purposing of an inexpensive drug to treat an epidemic, calling it “unproven,” not “backed by science,” “not a cure” and “shocking” to endorse, with The New York Times emphasizing no profit-driven drug company suggested it.
In President Trump’s first term, it was ivermectin and hydroxychloroquine to treat COVID-19. In his second, it’s prescription leucovorin to treat autism spectrum disorder.
Long used to treat chemotherapy side effects, leucovorin calcium tablets got approved last week by the Food and Drug Administration to treat “cerebral folate deficiency” (CFD), whose clinical symptoms include “global developmental delays with autistic features,” following its own “systematic analysis of literature” from 2009 through last year.
“Published case reports provided patient-level data on over 40 patients,” adult and child, with most of those given leucovorin treatment showing “substantial improvement of symptoms of CFD that would not be expected when compared to the natural history of CFD due to FOLR1 gene variants,” the Federal Register notice says.
Health and Human Services Secretary Robert F. Kennedy Jr. touted leucovorin to treat autism Monday with Trump and Centers for Medicare and Medicaid Services Administrator Mehmet Oz, but it was quickly overshadowed by the other autism-related recommendation that pregnant women limit their use of Tylenol, which prompted a new TikTok challenge.
Hellbound and Down 